These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31881123)

  • 41. Indicators of inappropriate tumour marker use through the mining of electronic health records.
    Gion M; Cardinali G; Trevisiol C; Zappa M; Rainato G; Fabricio ASC
    J Eval Clin Pract; 2017 Aug; 23(4):895-902. PubMed ID: 28503788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Application of C12 multi-tumor marker protein chip in the diagnosis of gastrointestinal cancer: results of 329 surgical patients and suggestions for improvement.
    Yang XQ; Yan L; Chen C; Hou JX; Li Y
    Hepatogastroenterology; 2009; 56(94-95):1388-94. PubMed ID: 19950797
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer.
    Feng F; Tian Y; Xu G; Liu Z; Liu S; Zheng G; Guo M; Lian X; Fan D; Zhang H
    BMC Cancer; 2017 Nov; 17(1):737. PubMed ID: 29121872
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
    Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
    Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Postoperative serum CA19-9, CEA and CA125 predicts the response to adjuvant chemoradiotherapy following radical resection in pancreatic adenocarcinoma.
    Xu HX; Li S; Wu CT; Qi ZH; Wang WQ; Jin W; Gao HL; Zhang SR; Xu JZ; Liu C; Long J; Xu J; Ni QX; Yu XJ; Liu L
    Pancreatology; 2018 Sep; 18(6):671-677. PubMed ID: 30153903
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diagnostic value of periostin in lung cancer-related malignant pleural effusion.
    Zhang J; Zha T; Zhang N; Sun G
    J Clin Lab Anal; 2022 Feb; 36(2):e24179. PubMed ID: 35152510
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L; Xie XW; Wang HY; Ma LY; Wen ZG
    Asian Pac J Cancer Prev; 2015; 16(12):4891-4. PubMed ID: 26163610
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer.
    Webb A; Scott-Mackie P; Cunningham D; Norman A; Andreyev J; O'Brien M; Bensted J
    Ann Oncol; 1995 Jul; 6(6):581-7. PubMed ID: 8573538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Clinical Significance of CEA, CA19-9, and CA125 in Management of Appendiceal Adenocarcinoma.
    Yousef A; Yousef M; Zeineddine M; More A; Chowdhury S; Knafl M; Edelkamp P; Ito I; Gu Y; Pattalachinti V; Naini ZA; Zeineddine F; Peterson J; Alfaro K; Foo WC; Jin J; Bhutiani N; Higbie V; Scally C; Kee B; Kopetz S; Goldstein D; Uppal A; White MG; Helmink B; Fournier K; Raghav K; Taggart M; Overman MJ; Shen JP
    medRxiv; 2023 Sep; ():. PubMed ID: 37745596
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Establishment and validation of reference intervals for tumor markers (AFP, CEA, CA19-9, CA15-3, CA125, PSA, HE4, Cyfra 21-1, and ProGRP) in primary care centers in Korea: A cross-sectional retrospective study.
    Nah EH; Cho S; Park H; Kim S; Kwon E; Cho HI
    Health Sci Rep; 2023 Feb; 6(2):e1107. PubMed ID: 36789402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic value of cancer antigen 15-3 (CA15-3) detected by monoclonal antibodies (115D8 and DF3) in exudative pleural effusions.
    Shimokata K; Totani Y; Nakanishi K; Yamamoto M; Hasegawa Y; Kawatsu H; Sasou H; Murate T; Ichiyama S; Kurasawa T
    Eur Respir J; 1988 Apr; 1(4):341-4. PubMed ID: 3165069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Postoperative serum CEA and CA125 levels are supplementary to perioperative CA19-9 levels in predicting operative outcomes of pancreatic ductal adenocarcinoma.
    Xu HX; Liu L; Xiang JF; Wang WQ; Qi ZH; Wu CT; Liu C; Long J; Xu J; Ni QX; Yu XJ
    Surgery; 2017 Feb; 161(2):373-384. PubMed ID: 27838102
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Prognostic value of carcinoembryonic antigen, alpha fetoprotein, carbohydrate antigen 125 and carbohydrate antigen 19-9 in gastroenteropancreatic neuroendocrine neoplasms].
    Chen L; Zhang Y; Chen M; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1002-1008. PubMed ID: 28900990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Combined use of AFP, CEA, CA125 and CAl9-9 improves the sensitivity for the diagnosis of gastric cancer.
    He CZ; Zhang KH; Li Q; Liu XH; Hong Y; Lv NH
    BMC Gastroenterol; 2013 May; 13():87. PubMed ID: 23672279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pleural to serum CEA ratio in lung adenocarcinoma.
    Satoh H; Ishikawa H; Yamashita YT; Ohtsuka M; Sekizawa K
    Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):178-9. PubMed ID: 12069128
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum levels of CA15-3, AFP, CA19-9 and CEA tumor markers in cancer care and treatment of patients with impaired renal function on hemodialysis.
    Estakhri R; Ghahramanzade A; Vahedi A; Nourazarian A
    Asian Pac J Cancer Prev; 2013; 14(3):1597-9. PubMed ID: 23679242
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lactate dehydrogenase and serum tumor markers for predicting metastatic status in geriatric patients with lung adenocarcinoma.
    Ren X; Zhang Y; Lyu Y; Jin B; Guo H; Wu J; Li X; Liu X
    Cancer Biomark; 2019; 26(2):139-150. PubMed ID: 31356196
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative serum carcinoembryonic antigen, carbohydrate antigen19-9 and carbohydrate antigen 125 as prognostic factors for recurrence-free survival in colorectal cancer.
    Yang XQ; Chen C; Wang FB; Peng CW; Li Y
    Asian Pac J Cancer Prev; 2011; 12(5):1251-6. PubMed ID: 21875276
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Serum Tumor Markers in Combination for Clinical Diagnosis of Lung Cancer.
    Wu H; Wang Q; Liu Q; Zhang Q; Huang Q; Yu Z
    Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaccination with a mixed vaccine of autogenous and allogeneic breast cancer cells and tumor associated antigens CA15-3, CEA and CA125--results in immune and clinical responses in breast cancer patients.
    Jiang XP; Yang DC; Elliott RL; Head JF
    Cancer Biother Radiopharm; 2000 Oct; 15(5):495-505. PubMed ID: 11155821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.